Cargando…

A case of successfully resected metachronous gastric and gallbladder metastases from pancreatic body cancer

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) readily metastasizes to the lymph nodes, liver, lung, and peritoneum; however, gastric and gallbladder metastases are rare. We report a case of metachronous gastric and gallbladder metastases from PDAC. CASE PRESENTATION: The patient is a 71-year-o...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Makoto, Yoshitomi, Hideyuki, Kato, Atsushi, Furukawa, Katsunori, Takayashiki, Tsukasa, Kuboki, Satoshi, Takano, Shigetsugu, Sugiura, Kensuke, Kawasaki, Keishi, Miyazaki, Masaru, Ohtsuka, Masayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374494/
https://www.ncbi.nlm.nih.gov/pubmed/30758733
http://dx.doi.org/10.1186/s40792-019-0581-1
Descripción
Sumario:BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) readily metastasizes to the lymph nodes, liver, lung, and peritoneum; however, gastric and gallbladder metastases are rare. We report a case of metachronous gastric and gallbladder metastases from PDAC. CASE PRESENTATION: The patient is a 71-year-old man who underwent distal pancreatectomy for PDAC. Seventeen months after the surgery, a 30-mm nodule was detected at the lesser curvature of the stomach, which was diagnosed as recurrence of PDAC in the lymph nodes. He then received gemcitabine and S-1 combination chemotherapy for 6 months. Because tumor size remained approximately the same and tumor marker levels decreased, total gastrectomy and cholecystectomy were performed. Pathological examination showed well-differentiated tubular adenocarcinoma in the subserosa and muscularis propria of the stomach and gallbladder. The patient remains alive at 41 months after the second surgery with liver metastasis. CONCLUSION: We reported a rare case of metachronous gastric and gallbladder metastases from pancreatic body cancer.